Santeramo, Ruggiero
Damiani, Celeste
Wei, Jiefei
Montana, Giovanni
Brentnall, Adam R.
Funding for this research was provided by:
Cancer Research UK (C49757/A2868, C49757/A2868, C49757/A2868, C49757/A2868, C49757/A2868)
Article History
Received: 2 October 2023
Accepted: 20 January 2024
First Online: 7 February 2024
Declarations
:
: The data used in this manuscript were fully anonymized and made available for research following ethical approval from the NHS Health Research Agency (REC reference: 19/SC/0284, IRAS reference: 265403).
: AB declares income from Cancer Research UK arising from commercial use of the Tyrer-Cuzick (IBIS) breast cancer risk evaluator.